[EN] BICYCLIC HETEROCYCLES CAPABLE OF MODULATING T-CELL RESPONSES, AND METHODS OF USING SAME<br/>[FR] HÉTÉROCYCLES BICYCLIQUES APTES À MODULER DES RÉPONSES DES LYMPHOCYTES T, ET PROCÉDÉS D'UTILISATION ASSOCIÉS
申请人:NOGRA PHARMA LTD
公开号:WO2013178815A1
公开(公告)日:2013-12-05
The present disclosure is directed in part to bicyclic heterocycles, such as a compound represented by formula (I) or (II) as disclosed herein, and their use in treating medical disorders, such as immune inflammatory disorders such as Crohn's disease, ulcerative colitis, rheumatic disorders, psoriasis, and allergies. The compounds are contemplated to modulate T-Cell responses.
本公开涉及部分对于双环杂环化合物,例如本文所披露的由式(I)或(II)表示的化合物,以及它们在治疗医学疾病中的应用,如免疫性炎症性疾病,如克罗恩病、溃疡性结肠炎、风湿性疾病、牛皮癣和过敏症。这些化合物被认为可以调节T细胞反应。